載入...
Targeting the centriolar replication factor STIL synergizes with DNA damaging agents for treatment of ovarian cancer
Advanced ovarian cancer is an incurable disease. Thus, novel therapies are required. We wished to identify new therapeutic targets for ovarian cancer. ShRNA screen performed in 42 ovarian cancer cell lines identified the centriolar replication factor STIL as an essential gene for ovarian cancer cell...
Na minha lista:
| 發表在: | Oncotarget |
|---|---|
| Main Authors: | , , , , , , , , , , , , , , , , , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
Impact Journals LLC
2017
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5432342/ https://ncbi.nlm.nih.gov/pubmed/28423708 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.16068 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|